ArticleDiscover oncology2026

Exploratory multiomics analysis identifies WDR17 as a potential biomarker of tyrosine kinase inhibitor resistance in lung adenocarcinoma.

Yuan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.